156 related articles for article (PubMed ID: 38418235)
1. What can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England.
Morris M; Cook A; Dodkins J; Price D; Waller S; Hassan S; Nathan A; Aggarwal A; Payne HA; Clarke N; van der Meulen J; Nossiter J
BMJ Open; 2024 Feb; 14(2):e078284. PubMed ID: 38418235
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic differences in perception of provider cultural competence among patients with depression and anxiety symptoms: a retrospective, population-based, cross-sectional analysis.
Eken HN; Dee EC; Powers AR; Jordan A
Lancet Psychiatry; 2021 Nov; 8(11):957-968. PubMed ID: 34563316
[TBL] [Abstract][Full Text] [Related]
4. Ethnic inequalities in health-related quality of life among older adults in England: secondary analysis of a national cross-sectional survey.
Watkinson RE; Sutton M; Turner AJ
Lancet Public Health; 2021 Mar; 6(3):e145-e154. PubMed ID: 33516278
[TBL] [Abstract][Full Text] [Related]
5. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
Alba C; Zheng Z; Wadhera RK
JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.
Egger S; Hughes S; Smith DP; Chambers S; Kahn C; Moxey A; O'Connell DL
PLoS One; 2018; 13(3):e0193686. PubMed ID: 29513724
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
8. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.
O'Halloran AC; Holstein R; Cummings C; Daily Kirley P; Alden NB; Yousey-Hindes K; Anderson EJ; Ryan P; Kim S; Lynfield R; McMullen C; Bennett NM; Spina N; Billing LM; Sutton M; Schaffner W; Talbot HK; Price A; Fry AM; Reed C; Garg S
JAMA Netw Open; 2021 Aug; 4(8):e2121880. PubMed ID: 34427679
[TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England.
Jack RH; Davies EA; Møller H
BJU Int; 2010 May; 105(9):1226-30. PubMed ID: 19878505
[TBL] [Abstract][Full Text] [Related]
11. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
Lai SM; Keighley J; Garimella S; Enko M; Parker WP
JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
[TBL] [Abstract][Full Text] [Related]
12. Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK.
Down L; Barlow M; Bailey SER; Mounce LTA; Merriel SWD; Watson J; Martins T
BMC Med; 2024 Mar; 22(1):82. PubMed ID: 38424555
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation.
Parry MG; Cowling TE; Sujenthiran A; Nossiter J; Berry B; Cathcart P; Aggarwal A; Payne H; van der Meulen J; Clarke NW; Gnanapragasam VJ
BMC Med; 2020 May; 18(1):114. PubMed ID: 32460859
[TBL] [Abstract][Full Text] [Related]
14. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of community provision of a preventive cardiovascular programme - the National Health Service Health Check in reaching the under-served groups by primary care in England: cross sectional observational study.
Woringer M; Cecil E; Watt H; Chang K; Hamid F; Khunti K; Dubois E; Evason J; Majeed A; Soljak M
BMC Health Serv Res; 2017 Jun; 17(1):405. PubMed ID: 28615019
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
[TBL] [Abstract][Full Text] [Related]
17. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
Defever K; Platz EA; Lopez DS; Mondul AM
Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
[TBL] [Abstract][Full Text] [Related]
18. Understanding ethnic and other socio-demographic differences in patient experience of primary care: evidence from the English General Practice Patient Survey.
Lyratzopoulos G; Elliott M; Barbiere JM; Henderson A; Staetsky L; Paddison C; Campbell J; Roland M
BMJ Qual Saf; 2012 Jan; 21(1):21-9. PubMed ID: 21900695
[TBL] [Abstract][Full Text] [Related]
19. Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer.
Senft N; Hamel LM; Manning MA; Kim S; Penner LA; Moore TF; Carducci MA; Heath EI; Lansey DG; Albrecht TL; Wojda M; Jordan A; Eggly S
JAMA Oncol; 2020 Nov; 6(11):1773-1777. PubMed ID: 32940630
[TBL] [Abstract][Full Text] [Related]
20. How representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control study.
Alessy SA; Davies EA; Rawlinson J; Baker M; Lüchtenborg M
BMJ Open; 2019 Dec; 9(12):e034344. PubMed ID: 31848175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
